These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38817193)

  • 1. X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model.
    Mou J; Ning XL; Wang XY; Hou SY; Meng FB; Zhou C; Wu JW; Li C; Jia T; Wu X; Wu Y; Chen Y; Li GB
    J Med Chem; 2024 Jun; 67(11):8730-8756. PubMed ID: 38817193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.
    Huang KF; Liaw SS; Huang WL; Chia CY; Lo YC; Chen YL; Wang AH
    J Biol Chem; 2011 Apr; 286(14):12439-49. PubMed ID: 21288892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the binding mode of PQ912 against secretory glutaminyl cyclase through systematic exploitation of conformational ensembles.
    Chandran R; Dileep KV
    Chem Biol Drug Des; 2021 Nov; 98(5):850-856. PubMed ID: 34423556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.
    Van Manh N; Hoang VH; Ngo VTH; Ann J; Jang TH; Ha JH; Song JY; Ha HJ; Kim H; Kim YH; Lee J; Lee J
    Eur J Med Chem; 2021 Dec; 226():113819. PubMed ID: 34536669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases.
    Zhang Y; Wang Y; Zhao Z; Peng W; Wang P; Xu X; Zhao C
    Eur J Pharmacol; 2022 Sep; 931():175178. PubMed ID: 35948163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and kinetic characterization of
    Lamers S; Feng Q; Cheng Y; Yu S; Sun B; Lukman M; Jiang J; Ruiz-Carrillo D
    Biol Chem; 2021 Jun; 402(7):759-768. PubMed ID: 33823093
    [No Abstract]   [Full Text] [Related]  

  • 8. Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.
    Hoang VH; Ngo VTH; Cui M; Manh NV; Tran PT; Ann J; Ha HJ; Kim H; Choi K; Kim YH; Chang H; Macalino SJY; Lee J; Choi S; Lee J
    J Med Chem; 2019 Sep; 62(17):8011-8027. PubMed ID: 31411468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors.
    Dileep KV; Sakai N; Ihara K; Kato-Murayama M; Nakata A; Ito A; Sivaraman DM; Shin JW; Yoshida M; Shirouzu M; Zhang KYJ
    Int J Biol Macromol; 2021 Feb; 170():415-423. PubMed ID: 33373636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.
    Hoffmann T; Meyer A; Heiser U; Kurat S; Böhme L; Kleinschmidt M; Bühring KU; Hutter-Paier B; Farcher M; Demuth HU; Lues I; Schilling S
    J Pharmacol Exp Ther; 2017 Jul; 362(1):119-130. PubMed ID: 28446518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold.
    Ramsbeck D; Buchholz M; Koch B; Böhme L; Hoffmann T; Demuth HU; Heiser U
    J Med Chem; 2013 Sep; 56(17):6613-25. PubMed ID: 23886302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.
    Hoang VH; Tran PT; Cui M; Ngo VT; Ann J; Park J; Lee J; Choi K; Cho H; Kim H; Ha HJ; Hong HS; Choi S; Kim YH; Lee J
    J Med Chem; 2017 Mar; 60(6):2573-2590. PubMed ID: 28234463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region.
    Ngo VTH; Hoang VH; Tran PT; Ann J; Cui M; Park G; Choi S; Lee J; Kim H; Ha HJ; Choi K; Kim YH; Lee J
    Bioorg Med Chem; 2018 Mar; 26(5):1035-1049. PubMed ID: 29398442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders.
    Pozzi C; Di Pisa F; Benvenuti M; Mangani S
    J Biol Inorg Chem; 2018 Dec; 23(8):1219-1226. PubMed ID: 30132075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer's Disease.
    Gulcan HO; Mavideniz A; Sahin MF; Orhan IE
    Curr Med Chem; 2019; 26(18):3260-3278. PubMed ID: 30678614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of flavonoids on human glutaminyl cyclase.
    Li M; Dong Y; Yu X; Zou Y; Zheng Y; Bu X; Quan J; He Z; Wu H
    Bioorg Med Chem; 2016 May; 24(10):2280-6. PubMed ID: 27061673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.
    Xu C; Zou H; Yu X; Xie Y; Cai J; Shang Q; Ouyang N; Wang Y; Xu P; He Z; Wu H
    ChemistryOpen; 2021 Sep; 10(9):877-881. PubMed ID: 33377311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease.
    Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA
    Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement.
    Buchholz M; Hamann A; Aust S; Brandt W; Böhme L; Hoffmann T; Schilling S; Demuth HU; Heiser U
    J Med Chem; 2009 Nov; 52(22):7069-80. PubMed ID: 19863057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.